Process for preparing lipase
    1.
    发明授权
    Process for preparing lipase 失效
    脂肪酶的制备方法

    公开(公告)号:US4791059A

    公开(公告)日:1988-12-13

    申请号:US844389

    申请日:1986-03-17

    IPC分类号: C12N9/20 C12P7/64 C12R1/44

    摘要: This invention relates to a process for preparation of a novel lipase. The process is characterized by culturing a microorganism belonging to Staphylococcus capitis and capable of producing lipase in a culture medium to accumulate lipase in the cultured broth and recovering the lipase from the broth. Since the pH of this lipase is in a slightly alkali region and the lipase substantially completely converts glyceride to fatty acids and glycerin, it is useful for the economic preparation of fatty acids by the hydrolysis of fats or oils.

    摘要翻译: PCT No.PCT / JP85 / 00409 Sec。 371日期:1986年3月17日 102(e)1986年3月17日PCT申请日1985年7月19日PCT公布。 第WO86 / 00925号公报 日本1986年2月13日。本发明涉及新型脂肪酶的制备方法。 该方法的特征在于培养属于葡萄球菌属的炎症微生物,并且能够在培养基中产生脂肪酶以在培养的肉汤中积聚脂肪酶并从肉汤中回收脂肪酶。 由于该脂肪酶的pH处于微碱性区域,脂肪酶基本上完全将甘油酯转化为脂肪酸和甘油,因此通过脂肪或油的水解来经济地制备脂肪酸是有用的。

    Angiotensin-converting enzyme inhibitory peptides
    3.
    发明授权
    Angiotensin-converting enzyme inhibitory peptides 有权
    血管紧张素转换酶抑制肽

    公开(公告)号:US07833985B2

    公开(公告)日:2010-11-16

    申请号:US10549176

    申请日:2004-03-17

    IPC分类号: A61K38/06

    CPC分类号: C07K5/0808 A61K38/00

    摘要: It is intended to provide ACE inhibitory tripeptides which are not easily digested by digestive enzymes after being orally taken and thus have fewer tendencies to lose their ACE inhibitory activity in vivo. More specifically, 3 tripeptides having an ACE inhibitory activity and showing a hypotensive effect in an animal experiment are discovered from a thermolysin digestion product of sesame. These tripeptides respectively have amino acid sequences Leu-Ser-Ala, Val-Ile-Tyr and Leu-Val-Tyr and show an angiotensin converting enzyme inhibitory activity.

    摘要翻译: 旨在提供ACE抑制性三肽,其在口服后不易被消化酶消化,因此具有较少的体内失去其ACE抑制活性的倾向。 更具体地,从芝麻的嗜热菌素消化产物中发现3种具有ACE抑制活性的三肽并且在动物实验中显示低血压作用。 这些三肽分别具有氨基酸序列Leu-Ser-Ala,Val-Ile-Tyr和Leu-Val-Tyr,并表现出血管紧张素转化酶抑制活性。

    Angiotensin-converting enzyme inhibitory peptides
    4.
    发明授权
    Angiotensin-converting enzyme inhibitory peptides 有权
    血管紧张素转换酶抑制肽

    公开(公告)号:US07943578B2

    公开(公告)日:2011-05-17

    申请号:US12483676

    申请日:2009-06-12

    IPC分类号: A61K38/06

    CPC分类号: C07K5/0808 A61K38/00

    摘要: It is intended to provide ACE inhibitory tripeptides which are not easily digested by digestive enzymes after being orally taken and thus have fewer tendencies to lose their ACE inhibitory activity in vivo.More specifically, 3 tripeptides having an ACE inhibitory activity and showing a hypotensive effect in an animal experiment are discovered from a thermolysin digestion product of sesame. These tripeptides respectively have amino acid sequences Leu-Ser-Ala, Val-Ile-Tyr and Leu-Val-Tyr and show an angiotensin converting enzyme inhibitory activity.

    摘要翻译: 旨在提供ACE抑制性三肽,其在口服后不易被消化酶消化,因此具有较少的体内失去其ACE抑制活性的倾向。 更具体地,从芝麻的嗜热菌素消化产物中发现3种具有ACE抑制活性的三肽并且在动物实验中显示低血压作用。 这些三肽分别具有氨基酸序列Leu-Ser-Ala,Val-Ile-Tyr和Leu-Val-Tyr,并表现出血管紧张素转化酶抑制活性。

    Angiotensin-converting enzyme inhibitory peptides
    5.
    发明申请
    Angiotensin-converting enzyme inhibitory peptides 有权
    血管紧张素转换酶抑制肽

    公开(公告)号:US20060276627A1

    公开(公告)日:2006-12-07

    申请号:US10549176

    申请日:2004-03-17

    IPC分类号: A61K38/05 C07K5/06

    CPC分类号: C07K5/0808 A61K38/00

    摘要: It is intended to provide ACE inhibitory tripeptides which are not easily digested by digestive enzymes after being orally taken and thus have fewer tendencies to lose their ACE inhibitory activity in vivo. More specifically, 3 tripeptides having an ACE inhibitory activity and showing a hypotensive effect in an animal experiment are discovered from a thermolysin digestion product of sesame. These tripeptides respectively have amino acid sequences Leu-Ser-Ala, Val-Ile-Tyr and Leu-Val-Tyr and show an angiotensin converting enzyme inhibitory activity.

    摘要翻译: 旨在提供ACE抑制性三肽,其在口服后不易被消化酶消化,因此具有较少的体内失去其ACE抑制活性的倾向。 更具体地,从芝麻的嗜热菌素消化产物中发现3种具有ACE抑制活性的三肽并且在动物实验中显示低血压作用。 这些三肽分别具有氨基酸序列Leu-Ser-Ala,Val-Ile-Tyr和Leu-Val-Tyr,并表现出血管紧张素转化酶抑制活性。

    LIGAND AGENTS FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPARs)
    6.
    发明申请
    LIGAND AGENTS FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPARs) 审中-公开
    过氧化物酶促活化受体(PPAR)的配体药剂

    公开(公告)号:US20100249248A1

    公开(公告)日:2010-09-30

    申请号:US12739568

    申请日:2008-10-24

    摘要: The present invention aims to provide ligand agents for peroxisome proliferator-activated receptors (PPARs), etc.The ligand agents of the present invention are characterized by comprising, as an active ingredient, an extract of one or more plants selected from the following:Serenoa repens, Acanthopanax senticosus, Euterpe oleracea, Elettaria cardamomum, Angelica archangelica, Psidium guajava, Prumus spinosa, Eleagnus multiflora, Ligusticum chuaxiong, Cannabis sativa, Sambucus nigra, Adinandra nitida, Passiflora incarnata, Peucedanum japonicum, Pimpinella anisum, Vitex agnus-castus, Withania somnifera, Calluna vulgaris, Crataegus monogyna, Linum usitatissimum, Pleurotus ferulae, Robinia pseudoacacia, and Acanthopanax sessiliflorus.

    摘要翻译: 本发明的目标是提供过氧化物酶体增殖物激活受体(PPARs)等的配体试剂。本发明的配体试剂的特征在于,作为活性成分包含选自以下的一种或多种植物的提取物:Serenoa rep ens,,,ania,,,,,,,,,,,,,,iva iva,,,ida ida ida ida ida ida,ata ata um um um um,ania ania ania ania ania ania ania ania ania ania ania ania ania ania ania ania ania ania ania ania ania ania ania ania 嗜睡,寻常,,,Cr a a a,imum imum,,,,,,。。。。。。。。。。。。。。。。。。。。。。。。。。